Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
May 24, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- AHRQ Policy on the Inclusion of Priority Populations in Research
Agency for Healthcare Research and Quality
- Announcing New Inbox for Inquiries Related to Changes to Biographical Sketch and Other Support Format Page
National Institutes of Health
General Notices
- Notice of Information: Availability of DNA and RNA Samples from the NIAAA-Sponsored Clinical Trial of Gabapentin Enacarbil Extend-Release
National Institute on Alcohol Abuse and Alcoholism
- Notice of Information: NIDA Extensions for NRSA Fellowships and Career Development Award Recipients Whose Career Trajectories Have Been Significantly Affected by COVID-19
National Institute on Drug Abuse
- Notice of Pre-Application Information Webinar for PAR-21-183, "Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)"
National Institute on Drug Abuse
- NIDDK Notice of Continuation of Temporary Extension of Eligibility for the NIH Mentored Research Scientist Development Award (K01) Award During the COVID-19 Pandemic
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of a Pre-Application Technical Assistance Webinar for NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
- Notice to Extend the Response Date for NOT-OD-21-108 "Request for information (RFI) on enhancing the science for the Environmental influences on Child Health Outcomes (ECHO) program"
National Institutes of Health
- Request for Information (RFI): Inviting Comments and Suggestions on the Impact of Radiation Exposure from a Radiological or Nuclear Incident on the Microbiome and the Development of Targeted Therapeutics
National Institute of Allergy and Infectious Diseases
- Request for Information (RFI): Inviting Comments on Developing Evidence-Based Music Therapies for Brain Disorders of Aging
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- Request for Information (RFI): Access and use of data from the Adolescent Brain Cognitive Development (ABCD) Study
National Institute on Drug Abuse
National Institute of Mental Health
- Request for Information: Input to the National Eye Institute Strategic Plan Draft Document
National Eye Institute
Notice of Changes to Funding Opportunities
- Notice of Change to Award Information in PAR-21-082, "NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- Notice of Change of Second Available Due Date for NOT-HD-20-008, Notice of Special Interest: Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Participation of NIMH in PAR-20-125, "Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)"
National Institute of Mental Health
- Notice of Early Termination of RFA-NS-21-016, HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
- Notice to Extend the Expiration Date for PA-18-590 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
National Institutes of Health
- Correction to the Budget Section of PAR-21-225"Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)"
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Correction to the Budget Section of "PAR-21-226 Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)"
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Correction to the Eligibility Section of PAR-21-238 "Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Notice of Participation of the Office of Research on Women's Health (ORWH) in PAR-20-214, "Research to Improve Native American Health (R21 Clinical Trials Optional)"
Office of Research on Women's Health
- Notice of Participation of the Office of Research on Women's Health (ORWH) in PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
Office of Research on Women's Health
- Notice of Addition of Information for RFA-RM-21-021 - Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
Office of Strategic Coordination (Common Fund)
- Notice of Addition of Information for RFA-RM-21-022 - Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
Office of Strategic Coordination (Common Fund)
Notices of Special Interest
- Notice of Special Interest: Advanced Computational Approaches to Elucidate Disease Pathology and Identify Novel Therapeutics for Addiction
National Institute on Drug Abuse
- Notice of Special Interest: Administrative Supplements to Support Research on Health Equity in NIDA-funded Grant Awards
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Administrative Supplements to support engagement of functionally diverse teams to advance ongoing NIDA-funded research
National Institute on Drug Abuse
- Notice of Special Interest (NOSI) to Encourage Administrative Supplement Applications to Investigate COVID-19 Vaccination and Menstruation (Admin Supp Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Special Interest (NOSI): Re-issue of Availability of Administrative Supplements for Submission of Tissue Chip Data to the Microphysiology Systems Database (MPS-Db)
National Center for Advancing Translational Sciences
Funding Opportunities
- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
National Institute on Drug Abuse
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
- NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke
- Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.